<DOC>
	<DOCNO>NCT01435083</DOCNO>
	<brief_summary>The objective study find pharmacokinetic/dynamic ( PK/PD ) characteristic desmopressin melt nocturia patient ( compare healthy volunteer child ) . The main question investigator want answer : - Are difference related pathophysiological factor involve nocturia ? - Are age/gender/size difference ? - Can investigator identify patient likely develop hyponatraemia ? - Can investigator individualize treatment reduce risk hyponatraemia ? Day 1 : - Patient hospitalize morning - General anamnesis clinical examination - Uroflow residue measurement ( 3x ) - Sober blood sample , determine plasma concentration Na+ , Cl- , osmolality creatinin Day 1-2 : - In even 20h : - start ( empty bladder ! ) 24h miction-incontinence-residue registration : urine collection every 3 hour ( every portion urine within period 3 hour must collect collection device ) , : registration volume measurement urinary concentration Na+ , Cl- , osmolality creatinin - Measurement blood pressure 24h Day 2-3 : - In even 19h ( day 2 ) : drink 15mL/kg water - At 20h : take desmopressin melt 120Âµg + start : - 24h miction-incontinence-residue registration : registration volume measurement urinary concentration Na+ , Cl- , osmolality creatinin ( U1-U7 ) - Measurement blood pressure 24h - Collection urine : U1 19h , U2 20h , together intake first desmopressin melt , U3 21h = 1h desmopressin melt intake , U4 22h = 2 desmopressin melt intake , U5 23h = 3h desmopressin melt intake , U6 2h ( day 3 ) = 6h desmopressin melt intake , U7 8h = 12h desmopressin melt intake - Blood sample blood level desmopressin : 1h , 2h , 3h , 6h desmopressin melt intake , 12h desmopressin melt intake + plasma concentration Na+ , Cl- , osmolality creatinin ( safety profile ) - At 8h morning ( day 3 ) : drink 15mL/kg water + collection urine per hour 3h measurement urinary concentration Na+ , Cl- , osmolality creatinin : U8 9h , U9 10h , U10 11h - Patient go home day 3 , unless high risk side effect , high-risk patient hospitalize 7 day</brief_summary>
	<brief_title>Desmopressin Melt Therapy Patients With Nocturnal Polyuria : Pharmacokinetic/Dynamic Study</brief_title>
	<detailed_description />
	<mesh_term>Polyuria</mesh_term>
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>write informed consent prior performance studyrelated activity patient , men woman , 18 year old , nocturnal polyuria , result nocturia ( 2 void night ) and/or nocturnal incontinence . hypersensitivity/anaphylactic reaction desmopressin one substances pregnancy genitourinary tract pathology ( infection , tumor , ... ) urolithiasis suspicion evidence cardiac failure moderate severe renal insufficiency ( creatinin clearance &lt; 50 ml/min ) psychogenic habitual polydipsia hyponatraemia predisposition hyponatraemia diabetes insipidus syndrome inadequate ADH production</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Nocturia</keyword>
</DOC>